Evidence map›Paper›PMID 35619126›Full record

ArticleBMC health services research2022

A strategy to identify event specific hospitalizations in large health claims databases.

Joshua Lambert, Harpal Sandhu, Emily Kean, Teenu Xavier, Aviv Brokman, Zachary Steckler, Lee Park, Arnold Stromberg

Abstract read
In one paragraph

Article in BMC health services research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Joshua LambertCollege of Nursing, University of Cincinnati, Procter Hall, Cincinnati, OH, 45219, USA. lambejw@ucmail.uc.edu.
Harpal SandhuDepartment of Bioengineering, University of Louisville Speed School of Engineering, Eastern Pkwy, Louisville, USA.
Emily KeanCollege of Nursing, University of Cincinnati, Procter Hall, Cincinnati, OH, 45219, USA.
Teenu XavierCollege of Nursing, University of Cincinnati, Procter Hall, Cincinnati, OH, 45219, USA.
Aviv BrokmanDr. Bing Zhang Department of Statistics, University of Kentucky, Lexington, USA.
Zachary StecklerDr. Bing Zhang Department of Statistics, University of Kentucky, Lexington, USA.
Lee ParkDr. Bing Zhang Department of Statistics, University of Kentucky, Lexington, USA.
Arnold StrombergDr. Bing Zhang Department of Statistics, University of Kentucky, Lexington, USA.

Funding

Identifying existing, FDA-approved drugs with clinically protective effects against coronavirus disease 2019 using a big data approachR21LM013683 · NLM · UNIVERSITY OF LOUISVILLE · PI LAMBERT, JOSH, SANDHU, HARPAL SINGH · 2021 to 2022
$443k
NIH NLM 7R21LM013683-02NLM NIH HHS R21 LM013683
6 · The paper itself

Abstract

backgroundHealth insurance claims data offer a unique opportunity to study disease distribution on a large scale. Challenges arise in the process of accurately analyzing these raw data. One important challenge to overcome is the accurate classification of study outcomes. For example, using claims data, there is no clear way of classifying hospitalizations due to a specific event. This is because of the inherent disjointedness and lack of context that typically come with raw claims data.

methodsIn this paper, we propose a framework for classifying hospitalizations due to a specific event. We then tested this framework in a private health insurance claims database (Symphony) with approximately 4 million US adults who tested positive with COVID-19 between March and December 2020. Our claims specific COVID-19 related hospitalizations proportion is then compared to nationally reported rates from the Centers for Disease Control by age.

resultsAcross all ages (18 +) the total percentage of Symphony patients who met our definition of hospitalized due to COVID-19 was 7.3% which was similar to the CDC's estimate of 7.5%. By age group, defined by the CDC, our estimates vs. the CDC's estimates were 18-49: 2.7% vs. 3%, 50-64: 8.2% vs. 9.2%, and 65 + : 14.6% vs. 28.1%.

conclusionsThe proposed methodology is a rigorous way to define event specific hospitalizations in claims data. This methodology can be extended to many different types of events and used on a variety of different types of claims databases.

Indexed as

COVID-19AdultDatabases, FactualHospitalizationHumansInsurance, HealthClaims dataClassificationCOVID-19COVID-19 research databaseMethodology

Identifiers

PMID35619126
PMCPMC9133593

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.